Delivery Order SPE2DB24D1034-SPE2DB24FWBU7

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $5,614.33 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 13, 2024, with a completion date of September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award is for the delivery of ADVAIR HFA 45-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA). The $2,049.57 firm fixed-price delivery order was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 9, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
The federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a total ceiling value of $1,639.62. The contract is a delivery order with a firm fixed price and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The contract has an award value of $9,142.92 and a completion date of September 20, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award, valued at $1,431.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADVAIR HFA 45-21 MCG INHALER 12GM, a pharmaceutical product, with a completion date of January 30, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
The federal government has awarded a delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, to supply 4,565,320,989 units of the ADVAIR HFA 115-21 MCG INHALER 12GM product. The $2,206.12 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, with an ultimate completion date of August 2, 2024. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM medical supplies. The $15,998.89 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 6, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of ADVAIR HFA 45-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $1,402.58 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 15, 2024 with a completion date of July 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA). The $9,590.46 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 24, 2024 with a completion date of July 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a primary vehicle for providing...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $2,385.99 with a firm fixed price. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply ADVAIR HFA 230-21 MCG INHALER 12GM to the agency. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB24FWBU7
    Delivery Order

The federal contract award is for the delivery of ADVAIR HFA 45-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA). The $1,509.56 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, with a performance period ending on August 19, 2024. This contract is a child order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/15/24, 9:02 AM